In a filing, Alpine Immune Sciences Inc revealed its insider Rickey James Paul unloaded Company’s shares for reported $2.75 million on Jan 26 ’24. In the deal valued at $23.32 per share,117,764 shares were sold. As a result of this transaction, Rickey James Paul now holds 0 shares worth roughly $0.0.
Then, Rickey James Paul sold 236 shares, generating $5,192 in total proceeds. Upon selling the shares at $22.00, the insider now owns 0 shares.
Before that, ORBIMED ADVISORS LLC sold 1,364,849 shares. Alpine Immune Sciences Inc shares valued at $25,049,034 were divested by the Director at a price of $18.35 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 264,315 shares, worth roughly $17.06 million.
Guggenheim initiated its Alpine Immune Sciences Inc [ALPN] rating to a Buy in a research note published on April 09, 2024; the price target was $55. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Berenberg began covering ALPN with “Buy” recommendation on October 18, 2023. Berenberg started covering the stock on October 17, 2023. It rated ALPN as “a Buy”.
Price Performance Review of ALPN
On Friday, Alpine Immune Sciences Inc [NASDAQ:ALPN] saw its stock fall -0.09% to $64.56. Over the last five days, the stock has gained 0.02%. Alpine Immune Sciences Inc shares have risen nearly 238.72% since the year began. Nevertheless, the stocks have risen 795.42% over the past one year. While a 52-week high of $64.70 was reached on 04/23/24, a 52-week low of $6.71 was recorded on 01/05/24. SMA at 50 days reached $43.37, while 200 days put it at $22.32. A total of 1.33 million shares were traded, compared to the trading of 1.18 million shares in the previous session.
Levels Of Support And Resistance For ALPN Stock
The 24-hour chart illustrates a support level at 64.50, which if violated will result in even more drops to 64.45. On the upside, there is a resistance level at 64.62. A further resistance level may holdings at 64.69. The Relative Strength Index (RSI) on the 14-day chart is 83.17, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.16, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 0.51%. Stochastics %K at 99.60% indicates the stock is a selling.
The most recent change occurred on October 05, 2023 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $19 price target.
